2010
Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, Massad LS, Watts DH, Kuniholm MH, Anastos K, Levine AM, Fazzari M, D'Souza G, Plankey M, Palefsky JM, Strickler HD. Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):159-69.
Althoff K, Gange SJ, Klein M, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Van Rompaey S, Zhang J, and Moore RD. Late Presentation for HIV Care in the United States and Canada. Accepted for publication, Clinical Infectious Diseases.
Chu H, Gange SJ, Li X, Hoover DR, Liu C, Chmiel JS, and Jacobson LP. The Effect of HAART on HIV RNA Trajectory among Treatment Naïve Men and Women: a Segmental Bernoulli/lognormal Random Effects Model with Left Censoring. Accepted for Publication, Epidemiology.
McMahon D, Jones J, Wiegand A, Gange SJ, …, Coffin JM, Mellors JW, and Maldarelli F. Short Course Raltegravir Intensification Does Not Reduce Persistent Low Level Viremia in Patients Suppressed on Combination Antiretroviral Therapy. Accepted for Publication, Clinical Infectious Diseases.
Merenstein D, Hu H, Robison E, Levine AM, Greenblatt RM, Schwartz R, Weber K, Young MA, Sharp G, Gange SJ, and Liu C. Relationship Between Complementary/Alternative Treatment
Use and illicit Drug Use among a Cohort of Women with or at Risk of HIV Infection. J Altern Complement Med 2010 [In press].
Ronquillo RE, Desai SN, Norris PJ, Golub ET, Greenblatt RM, Gange SJ, and Landay AL. Elevated Caspase-3 Expression and T Cell Activation in Elite Suppressors. J Acquir Immune Defic Syndr 2010 [In Press].
Aumakhan B, Gange SJ, Beyrer C, Gaydos CA, Minkoff H, Merenstein DJ, Cohen M, Anastos A, Greenblatt R, Nowicki M, and Quinn TC. Quantitative and Qualitative Correlates of Cervicovaginal HSV-2 Shedding Among HIV Infected Women in Women’s Interagency HIV Study. Int J STD AIDS 2010
Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, Carrington M. Specific HLA Class I and II Alleles Associated with Hepatitis C Virus Viremia. Accepted for publication, Hepatology.
Althoff K, Anastos K, Nelson KE, Celentano DD, Sharp GB, Greenblatt RM, French AL, Diamond DJ, Holman S, Young M, and Gange SJ. Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-7 and 2007-8 seasons. Provisionally accepted for publication, Preventive Medicine.
Palella FJ, Gange SJ, Benning L, Jacobson L, Kaplan RC, Landay AL, Tracy RP, Elion R. Inflammatory Biomarkers among Abacavir and non-Abacavir Recipients in the Women's Interagency HIV Study (WIHS) and Multicenter AIDS Cohort Study (MACS). Provisionally accepted for publication, AIDS.
2009
Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD for the NA-ACCORD Investigators. Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine, 2009;360:1815-26. [With Editorial Commentary]
Dinoso JB, Kim SY, Wiegand AM, Palmer SE, Gange SJ, Cranmer L, O'Shea A, Callender M, Spivak A, Brennan T, Kearney MF, Proschan MA, Mican JM, Rehm CA, Coffin JM, Mellors JW, Siliciano RF, Maldarelli F. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci (USA) 2009 Jun 9;106(23):9403-8. Epub 2009 May 22
Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. American Journal of Epidemiology 2009 Jul 15;170(2):244-56.
Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, and Moore RD for the North American AIDS Cohort Collaboration on Research and Design. Trends in Multi-Drug Failure and Subsequent Mortality among Antiretroviral Therapy-Experienced HIV-Infected Patients in North America. Clinical Infectious Diseases 2009 Nov 15;49(10):1582-90.
Abraham AG, Duncan DD, Gange SJ, West S. Computer-aided assessment of diagnostic images for epidemiological research. BMC Med Res Methodol. 2009 Nov 11;9(1):74.
Silverberg MJ, Jacobson LP, French AL, Witt MD, Gange SJ. Age and Racial/Ethnic Differences in the Prevalence of Reported Symptoms in Human Immunodeficiency Virus-Infected Persons on Antiretroviral Therapy. Journal of Pain and Symptom Management.2009 August;38(2):197-207.
Lau B, Gange SJ, Kirk GD, and Moore RD. Inferences from Clinical and Interval Cohort Studies with Application to the Evaluation of HIV Biomarkers. Epidemiology. 2009 Sep;20(5):664-72.
Galarraga O+, Salkever DS, Cook JA, Gange SJ. An instrumental variable evaluation of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004.Health Economics 2009 Feb 27;19(2):173-188. Also published in early form as a 2006 National Bureau of Economic Research Working Paper (#12619).
Terzian AS+, Holman S, Nathwani N, Robison E, Weber K, Young M, Greenblatt RM, and Gange SJ. Factors associated with preclinical disability and frailty among HIV-infected and –uninfected women in the era of cART. Journal of Women’s Health 2009 Dec;18(12):1965-74.
Cheskin LJ & Gange SJ. BMI <22.5 and >25 predicted higher overall mortality in adults. Evid Based Med. 2009 Oct;14(5):152.
Mansoor A, Althoff K, Gange S, Anastos K, DeHovitz J, Minkoff H, Kaplan R, Holman S, Lazar J. Elevated N-terminal-pro-brain natriuretic peptide levels are associated with comorbidities among HIV infected women. AIDS Research and Human Retroviruses 2009 Oct;25(10):997-1004.
Sethi AJ and Gange SJ. Parametric models as an alternative to Cox proportional hazards regression to analyze time to event data. Wisconsin Medical Journal 2009 Aug;108(5):266-8.
Liu C, Yang Y, Gange S, Weber K, Sharp G, Wilson T, Levine A, Robison E, Gandhi M, Merenstein D. Disclosure of complimentary and alternative medicine use to health care providers among HIV-infected women. AIDS Patient Care STDS. 2009 Nov;23(11):965-71.
Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, and Greenblatt RM. NNRTI pharmacokinetics in a large unselected cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):482-91.
Ganesan A, Benning L, Golub ET, Riddle M, Crum-Cianflone N, Tasker S, Jacobson L, and Gange SJ. Serum Lipid Profiles among Patients Initiating Ritonavir-Boosted Atazanavir versus Efavirenz-Based Regimens. AIDS Res Ther. 2009 Jun 22;6:13.
Templeton AR, Kramer MG, Jarvis J, Kowalski J, Gange S, Schneider MF, Shao Q, Zhang GW, Yeh MF, Tsai HL, Zhang H, and Markham RB. Multiple-infection and Recombination in HIV-1 Within A Longitudinal Cohort of Women. Retrovirology 2009 Jun 3;6(1):54.
Phelan DF+, Gange SJ, Ahdieh-Grant L, Mehta SH, Kirk GD, Shah K, Gravitt P. Determinants of Newly Detected Human Papillomavirus Infection in HIV-Infected and HIV-Uninfected Injection Drug Using Women. Sex Transm Dis. 2009;36(3):149-156.
Feldman DN, Feldman JG, Greenblatt RM, Anastos K, Pearce L, Cohen MH, Gange SJ, Leanza S, and Burk R. CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women. AIDS Educ Prev 2009;21(3):
Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, and Greenblatt RM. Protease Inhibitor Levels in Hair Samples Strongly Predict Virologic Responses to HIV Treatment. AIDS 2009 Feb 20;23(4):471-478.
Kowalski J, Gange SJ, Schneider MF, Tsai H-L, Templeton A, Shao Q, Zhang QW, Yeh MF, Young M, and Markham RB. Relationship of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 pol Gene. J Acquir Immune Defic Syndr 2009;50:381–389.
+ Students or supervised staff
